Compounds > chitosan

Page last updated: 2024-08-25

chitosan and oridonin

chitosan has been researched along with oridonin in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Duan, C; Feng, F; Jia, L; Liu, Y; Tian, K; Wang, F; Wang, Y; Zhang, D; Zhang, Q; Zheng, D	1
Duan, C; Gao, J; Jia, L; Liu, G; Liu, Y; Tian, X; Wang, F; Zhang, D; Zhang, Q; Zheng, D	1
Duan, C; Guo, H; Jia, L; Li, C; Liu, G; Liu, Y; Wang, F; Zhang, D; Zhang, Q; Zheng, D	1

Other Studies

3 other study(ies) available for chitosan and oridonin

Article	Year
Chitosan-g-poly(N-isopropylacrylamide) based nanogels for tumor extracellular targeting. International journal of pharmaceutics, 2011, May-16, Volume: 409, Issue:1-2 Topics: Acrylamides; Acrylic Resins; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Chitosan; Diterpenes, Kaurane; Drug Carriers; Drug Delivery Systems; Gels; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Magnetic Resonance Spectroscopy; Nanoparticles; Polymers; Spectroscopy, Fourier Transform Infrared	2011
Galactose-decorated pH-responsive nanogels for hepatoma-targeted delivery of oridonin. Biomacromolecules, 2011, Dec-12, Volume: 12, Issue:12 Topics: Acrylamides; Carcinoma, Hepatocellular; Chitosan; Diterpenes, Kaurane; Drug Carriers; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Nanogels; Polyethylene Glycols; Polyethyleneimine	2011
Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin. International journal of pharmaceutics, 2012, Oct-15, Volume: 436, Issue:1-2 Topics: Animals; Antineoplastic Agents; Area Under Curve; Chitosan; Diterpenes, Kaurane; Drug Carriers; Galactose; Hepatocytes; Mice; Nanoparticles; Rats; Rats, Sprague-Dawley; Tissue Distribution	2012